Injectable dermal fillers are engineered biomaterials, and their in vivo clinical performance is directly linked to their material composition. However, translation of intrinsic material properties into anatomy-informed clinical decisions remains inadequately characterized. As a clinical companion to Part A, which established the material science and rheological foundations of contemporary filler design, this Part B review bridges those material properties to the practical domains of filler selection, injection technique, outcome assessment, and complication management. Across hyaluronic acid (HA) formulations, collagen-based agents, and biostimulatory agents such as calcium hydroxylapatite and poly-L-lactic acid (PLLA), clinical performance is shown to be governed by the interplay of storage modulus (G'), loss modulus (G″), cohesivity, and degradation kinetics. To achieve desired aesthetic results, clinicians must weigh these rheological properties with the specific biomechanical demands of different facial regions. Anatomy-informed injection techniques are shown to be an extension of material behavior, in which depth, instrument selection, and volume deposition are all informed by filler rheology and regional vascular anatomy. These factors should be considered to improve safety and manage complications. As cosmetic procedures shift from simple volumetric replacement toward bioactive tissue remodeling, future advances will likely depend on integrated, hybrid formulations that couple structural correction with controlled regeneration.
Shah et al. (2026) studied this question.